Work

Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality

Year: 2025

Type: article

Study design: Observational Study

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/apt.70409

Authors: Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Rohit Loomba, Aijaz Ahmed

Institutions: Stanford Medicine, Stanford University, Texas Tech University, Texas Tech University Health Sciences Center, Banner - University Medical Center Phoenix, University of Arizona College of Medicine- Phoenix, University of California San Diego

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

Funders: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1494183008, G1622551803, Non-invasive screening of diabetics for advanced fibrosis due to NAFLD, Novel IL-23 inhibitor for the treatment of alcohol associated liver disease, G745677937, G7501542120, GENETIC EPIDEMIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE, Multidisciplinary Research Training in Digestive Physiology and Diseases, San Diego Digestive Diseases Research Center, Clinical Research on Nonalcoholic Fatty Liver Disease, San Diego Cirrhosis Clinical Research Network

OpenAlex ID: W4415219169

FWCI: 4.857

Cites: 39

Cited by: 8

Related to: